MX337050B - Compuestos 4'-azido-nucleósidos como anti-vhc. - Google Patents
Compuestos 4'-azido-nucleósidos como anti-vhc.Info
- Publication number
- MX337050B MX337050B MX2012008443A MX2012008443A MX337050B MX 337050 B MX337050 B MX 337050B MX 2012008443 A MX2012008443 A MX 2012008443A MX 2012008443 A MX2012008443 A MX 2012008443A MX 337050 B MX337050 B MX 337050B
- Authority
- MX
- Mexico
- Prior art keywords
- hcv
- compunds
- nucleosides
- azido
- hepatitis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Abstract
Compuestos que presentan la fórmula I, en la que R1, R2 y R3 son tal como se define en la presente memoria, inhibidores de la polimerasa NS5b del virus de la hepatitis C. También se dan a conocer composiciones y métodos para el tratamiento de una infección por VHC y para inhibir la replicación del VHC (Ver Formula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29922910P | 2010-01-28 | 2010-01-28 | |
PCT/EP2011/050971 WO2011092158A1 (en) | 2010-01-28 | 2011-01-25 | 4 ' - azido - nucleosides as anti - hcv compunds |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012008443A MX2012008443A (es) | 2012-08-15 |
MX337050B true MX337050B (es) | 2016-02-10 |
Family
ID=43587111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012008443A MX337050B (es) | 2010-01-28 | 2011-01-25 | Compuestos 4'-azido-nucleósidos como anti-vhc. |
Country Status (16)
Country | Link |
---|---|
US (1) | US8236779B2 (es) |
EP (1) | EP2528930B1 (es) |
JP (1) | JP5675849B2 (es) |
KR (1) | KR101384389B1 (es) |
CN (1) | CN102725303B (es) |
BR (1) | BR112012015951A2 (es) |
CA (1) | CA2784330C (es) |
DK (1) | DK2528930T3 (es) |
ES (1) | ES2437933T3 (es) |
HK (1) | HK1176938A1 (es) |
MX (1) | MX337050B (es) |
PL (1) | PL2528930T3 (es) |
PT (1) | PT2528930E (es) |
RU (1) | RU2556991C2 (es) |
TW (1) | TW201141488A (es) |
WO (1) | WO2011092158A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2812962C (en) * | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
CA2843324A1 (en) | 2011-03-31 | 2012-11-15 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of viral infections |
AR088441A1 (es) | 2011-09-12 | 2014-06-11 | Idenix Pharmaceuticals Inc | Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales |
AR089650A1 (es) | 2011-10-14 | 2014-09-10 | Idenix Pharmaceuticals Inc | Fosfatos 3,5-ciclicos sustituidos de compuestos de nucleotido de purina y composiciones farmaceuticas para el tratamiento de infecciones virales |
WO2013177188A1 (en) | 2012-05-22 | 2013-11-28 | Idenix Pharmaceuticals, Inc. | 3',5'-cyclic phosphoramidate prodrugs for hcv infection |
PE20150132A1 (es) | 2012-05-22 | 2015-02-14 | Idenix Pharmaceuticals Inc | Compuestos d-aminoacidos para enfermedad hepatica |
US9296778B2 (en) | 2012-05-22 | 2016-03-29 | Idenix Pharmaceuticals, Inc. | 3′,5′-cyclic phosphate prodrugs for HCV infection |
CA2871547C (en) | 2012-05-25 | 2021-05-25 | Janssen R&D Ireland | Uracyl spirooxetane nucleosides |
WO2014052638A1 (en) | 2012-09-27 | 2014-04-03 | Idenix Pharmaceuticals, Inc. | Esters and malonates of sate prodrugs |
AP2015008384A0 (en) | 2012-10-08 | 2015-04-30 | Univ Montpellier Ct Nat De La Rech Scient | 2'-Chloro nucleoside analogs for hcv infection |
WO2014066239A1 (en) | 2012-10-22 | 2014-05-01 | Idenix Pharmaceuticals, Inc. | 2',4'-bridged nucleosides for hcv infection |
US9211300B2 (en) | 2012-12-19 | 2015-12-15 | Idenix Pharmaceuticals Llc | 4′-fluoro nucleosides for the treatment of HCV |
WO2014137930A1 (en) | 2013-03-04 | 2014-09-12 | Idenix Pharmaceuticals, Inc. | Thiophosphate nucleosides for the treatment of hcv |
US9309275B2 (en) | 2013-03-04 | 2016-04-12 | Idenix Pharmaceuticals Llc | 3′-deoxy nucleosides for the treatment of HCV |
WO2014160484A1 (en) | 2013-03-13 | 2014-10-02 | Idenix Pharmaceuticals, Inc. | Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv |
WO2014165542A1 (en) | 2013-04-01 | 2014-10-09 | Idenix Pharmaceuticals, Inc. | 2',4'-fluoro nucleosides for the treatment of hcv |
EP3004130B1 (en) | 2013-06-05 | 2019-08-07 | Idenix Pharmaceuticals LLC. | 1',4'-thio nucleosides for the treatment of hcv |
WO2015017713A1 (en) | 2013-08-01 | 2015-02-05 | Idenix Pharmaceuticals, Inc. | D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease |
WO2015161137A1 (en) | 2014-04-16 | 2015-10-22 | Idenix Pharmaceuticals, Inc. | 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv |
EP3845221B1 (en) * | 2014-06-13 | 2023-12-13 | Ratiopharm GmbH | Solid state forms of sofosbuvir |
HRP20211456T1 (hr) | 2014-12-26 | 2021-12-24 | Emory University | Protuvirusni derivati n4-hidroksicitidina |
WO2016204531A1 (ko) * | 2015-06-16 | 2016-12-22 | 엘지전자(주) | 블록 경계에 따라 적응적으로 필터링을 수행하는 방법 및 장치 |
US11331331B2 (en) | 2017-12-07 | 2022-05-17 | Emory University | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
CN113880903A (zh) * | 2021-09-23 | 2022-01-04 | 厦门蔚嘉制药有限公司 | 莫那比拉韦的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7094770B2 (en) * | 2000-04-13 | 2006-08-22 | Pharmasset, Ltd. | 3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
CN1646141B (zh) * | 2000-10-18 | 2014-06-25 | 吉利德制药有限责任公司 | 用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物 |
EP1707571B1 (en) * | 2001-01-22 | 2011-09-28 | Merck Sharp & Dohme Corp. | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
AU2003232071A1 (en) * | 2002-05-06 | 2003-11-17 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
TWI332507B (en) | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
CN100351264C (zh) * | 2002-11-19 | 2007-11-28 | 霍夫曼-拉罗奇有限公司 | 抗病毒核苷衍生物 |
ATE482690T1 (de) * | 2005-12-14 | 2010-10-15 | Hoffmann La Roche | Hcv-prodrug-formulierung |
US20090318380A1 (en) * | 2007-11-20 | 2009-12-24 | Pharmasset, Inc. | 2',4'-substituted nucleosides as antiviral agents |
CL2008003511A1 (es) * | 2007-11-29 | 2010-02-19 | Metabasis Therapeutics Inc | Compuestos derivados nucleotidicos, inhibidores de polimerasa ns5b del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. |
-
2011
- 2011-01-25 PL PL11701107T patent/PL2528930T3/pl unknown
- 2011-01-25 MX MX2012008443A patent/MX337050B/es active IP Right Grant
- 2011-01-25 PT PT117011072T patent/PT2528930E/pt unknown
- 2011-01-25 JP JP2012550415A patent/JP5675849B2/ja not_active Expired - Fee Related
- 2011-01-25 DK DK11701107.2T patent/DK2528930T3/da active
- 2011-01-25 BR BR112012015951A patent/BR112012015951A2/pt active Search and Examination
- 2011-01-25 RU RU2012136379/04A patent/RU2556991C2/ru not_active IP Right Cessation
- 2011-01-25 EP EP11701107.2A patent/EP2528930B1/en not_active Not-in-force
- 2011-01-25 WO PCT/EP2011/050971 patent/WO2011092158A1/en active Application Filing
- 2011-01-25 ES ES11701107.2T patent/ES2437933T3/es active Active
- 2011-01-25 CN CN201180007367.0A patent/CN102725303B/zh not_active Expired - Fee Related
- 2011-01-25 KR KR1020127022217A patent/KR101384389B1/ko not_active IP Right Cessation
- 2011-01-25 CA CA2784330A patent/CA2784330C/en not_active Expired - Fee Related
- 2011-01-25 TW TW100102705A patent/TW201141488A/zh unknown
- 2011-01-26 US US13/014,022 patent/US8236779B2/en not_active Expired - Fee Related
-
2013
- 2013-04-09 HK HK13104289.7A patent/HK1176938A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN102725303B (zh) | 2015-05-27 |
JP5675849B2 (ja) | 2015-02-25 |
RU2012136379A (ru) | 2014-03-10 |
EP2528930A1 (en) | 2012-12-05 |
BR112012015951A2 (pt) | 2018-10-16 |
MX2012008443A (es) | 2012-08-15 |
KR20120110177A (ko) | 2012-10-09 |
US20110150829A1 (en) | 2011-06-23 |
RU2556991C2 (ru) | 2015-07-20 |
TW201141488A (en) | 2011-12-01 |
US8236779B2 (en) | 2012-08-07 |
KR101384389B1 (ko) | 2014-04-10 |
DK2528930T3 (da) | 2013-11-11 |
CN102725303A (zh) | 2012-10-10 |
CA2784330A1 (en) | 2011-08-04 |
WO2011092158A1 (en) | 2011-08-04 |
PL2528930T3 (pl) | 2014-03-31 |
HK1176938A1 (en) | 2013-08-09 |
JP2013518076A (ja) | 2013-05-20 |
EP2528930B1 (en) | 2013-10-30 |
PT2528930E (pt) | 2013-11-26 |
CA2784330C (en) | 2018-02-13 |
ES2437933T3 (es) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX337050B (es) | Compuestos 4'-azido-nucleósidos como anti-vhc. | |
MX2012003170A (es) | Compuestos heterociclicos antivirales. | |
MX2010004623A (es) | Compuestos heterociclicos antiviricos. | |
MX2009008872A (es) | Compuestos macrociclicos como inhibidores de proteasa ns3 del virus de hepatitis c. | |
MY152070A (en) | Macrocyclic quinxaline compounds as hcv ns3 protease inhibitors | |
MY157435A (en) | Heterocyclic antiviral compounds | |
SI1987038T1 (sl) | Hcv ns5b inhibitorji | |
MX2009004888A (es) | Inhibidores del virus de la hepatitis c. | |
HK1128131A1 (en) | Hepatitis c virus inhibitors | |
TW200745120A (en) | Indolobenzazepine HCV NS5B inhibitors | |
MX2011009644A (es) | Inhibidores del virus de la hepatitis c. | |
TW200745151A (en) | Antiviral nucleosides | |
MX2012000959A (es) | Inhibidores de los virus flaviviridae. | |
MX2009009473A (es) | Compuestos para el tratamiento de hepatitis c. | |
MX2011006631A (es) | Inhibidores de proteasa ns3 del virus hcv. | |
WO2009069095A3 (en) | Antiviral nucleoside compounds | |
MX2010005226A (es) | Inhibidores de ns5b de hcv de indolobenzazepina fusionados a ciclopropilo. | |
MX2013002927A (es) | Inhibidores del virus de la hepatitis c. | |
MX2011012541A (es) | Compuestos heterociclicos antivirales. | |
MX2012006513A (es) | Compuestos heterociclicos antivirales. | |
MX2010001416A (es) | Compuesto para el tratamiento de la hepatitis c. | |
WO2012019299A9 (en) | Hepatitis c inhibitor compounds | |
MX2011011112A (es) | Compuestos antivirales heterociclicos. | |
MX2011012240A (es) | Compuestos heterociclicos antivirales. | |
MX2010010061A (es) | Compuestos para el tratamiento de hepatitis c. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: RIBOSCIENCE LLC |
|
FG | Grant or registration |